Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$12.4 - $17.6 $1.62 Million - $2.3 Million
-130,763 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$11.59 - $14.93 $49,106 - $63,258
-4,237 Reduced 3.14%
130,763 $1.73 Million
Q2 2020

Aug 13, 2020

BUY
$11.79 - $15.97 $117,899 - $159,700
10,000 Added 8.0%
135,000 $1.69 Million
Q1 2020

May 15, 2020

BUY
$9.31 - $21.24 $397,592 - $907,075
42,706 Added 51.89%
125,000 $1.68 Million
Q4 2019

Feb 13, 2020

BUY
$13.91 - $21.48 $1.14 Million - $1.77 Million
82,294 New
82,294 $1.65 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $329M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.